Mark Boguski on His New Job as Director of Paul Allen s Post-Genomic Brainchild | GenomeWeb

Mark Boguski cut his teeth at NCBI at the height of the genome sequencing era before moving on to lead R&D at Rosetta Inpharmatics just as the field of microarray analysis was taking off; in other words, his career has mirrored major shifts in the field of bioinformatics itself. And, judging from Boguski’s latest appointment as director of the newly launched Allen Institute for Brain Science, it looks like the discipline may be poised for another shakeup.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.